医疗美容业务仍然为集团收益的主要引擎，贡献总销售的73.3%，而非医疗美容则贡献其余部分。每名医疗美容服务客户的平均消费同期下跌36.6%至17,243港元，反映客户消费行为转向更为物超所值的选择。Perfect Healthcare (01830) announced results for the six months ended September 30, 2024, with revenue of HK$0.62 billion,...
According to the Zhitong Finance App, Perfect Healthcare (01830) announced results for the six months ended September 30, 2024, with revenue of HK$0.62 billion, down 13.6% year on year; profit attributable to the company's equity holders was HK$0.141 billion, down 15.4% year on year; basic profit per share was 11.2 HK cents. The proposed interim dividend and special dividend were 11.2 HK cents and 0.1 HK cents per share, with a total dividend of HK$11.3 per share.
During the period, the Group faced challenges in all operating regions, but it still showed resilience in maintaining core operations under the pressure of a challenging economic environment. Earnings during the period decreased by 13.6% over the same period. The decrease was mainly due to reduced demand in Hong Kong and mainland China, and increased outbound travel affecting local retail consumption.
The medical aesthetic business remains the main engine of the Group's revenue, contributing 73.3% of total sales, while non-medical aesthetics contributes the rest. The average spending per medical and aesthetic service customer fell 36.6% to HK$17,243 over the same period, reflecting a shift in customer spending behavior towards more value-for-money choices.
